Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
909.81
-20.54 (-2.21%)
Mar 18, 2026, 10:20 AM EDT - Market open
Eli Lilly Stock Forecast
Stock Price Forecast
The 19 analysts that cover Eli Lilly stock have a consensus rating of "Buy" and an average price target of $1,182, which forecasts a 29.96% increase in the stock price over the next year. The lowest target is $830 and the highest is $1,500.
Price Target: $1,182 (+29.96%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Eli Lilly stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 8 | 8 | 9 | 7 | 7 |
| Buy | 5 | 7 | 7 | 7 | 9 | 9 |
| Hold | 2 | 3 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 18 | 18 | 19 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HSBC | HSBC | Hold → Sell Downgrades $1,070 → $850 | Hold → Sell | Downgrades | $1,070 → $850 | -6.57% | Mar 17, 2026 |
| RBC Capital | RBC Capital | Buy Initiates $1,250 | Buy | Initiates | $1,250 | +37.39% | Feb 25, 2026 |
| Barclays | Barclays | Buy Initiates $1,350 | Buy | Initiates | $1,350 | +48.38% | Feb 20, 2026 |
| Deutsche Bank | Deutsche Bank | Strong Buy Maintains $1,200 → $1,285 | Strong Buy | Maintains | $1,200 → $1,285 | +41.24% | Feb 9, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $1,150 → $1,300 | Buy | Maintains | $1,150 → $1,300 | +42.89% | Feb 5, 2026 |
Financial Forecast
Revenue This Year
82.80B
from 65.18B
Increased by 27.04%
Revenue Next Year
96.27B
from 82.80B
Increased by 16.26%
EPS This Year
34.96
from 22.95
Increased by 52.32%
EPS Next Year
42.70
from 34.96
Increased by 22.16%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 93.0B | 109.1B | |||
| Avg | 82.8B | 96.3B | |||
| Low | 77.9B | 86.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 42.7% | 31.7% | |||
| Avg | 27.0% | 16.3% | |||
| Low | 19.6% | 4.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 39.92 | 48.81 | |||
| Avg | 34.96 | 42.70 | |||
| Low | 32.63 | 37.60 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 73.9% | 39.6% | |||
| Avg | 52.3% | 22.2% | |||
| Low | 42.2% | 7.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.